Versa Vascular Secures $27.3M Oversubscribed Series C Funding and Appoints David Hovda as CEO to Advance Novel Tricuspid Valve Repair Technology
Previous
Previous
Opine Raises $5M to Build Unified AI Workspace For Complex B2B Sales
Next
Next